Want to see NVO full AI Analyst Report?
Novo Nordisk (NVO) Stock Forecast & Price Target
NVO Analyst Ratings
NVO Stock 12 Month Forecast
Average Price Target
$42.53▲(5.83% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Kerry Holford | Berenberg Bank | $47 | hold | 16.94%Upside | Reiterated | 10/13/26 | ||
| Evan Seigerman | BMO Capital | $47→$40 | hold | -0.47%Downside | Reiterated | 10/12/26 | ||
 Unknown AnalystNot Ranked | Jefferies | $42.20 | hold | 5.00%Upside | Reiterated | 09/22/26 | ||
| Michael Nedelcovych | TD Cowen | $42 | hold | 4.50%Upside | Reiterated | 09/22/26 | ||
| Thibault Boutherin | Morgan Stanley | $40 | sell | -0.47%Downside | Downgraded | 09/11/26 | ||
| Jasper Hellweg | Argus Research | ― | hold | ― | Reiterated | 08/07/26 | ||
| James Quigley | Goldman Sachs | $48→$44 | hold | 9.48%Upside | Reiterated | 08/06/26 | ||
| Martin Brenoe | Nordea Markets | ― | hold | ― | Downgraded | 02/24/26 | ||
| Emmanuel Papadakis | Deutsche Bank | ― | hold | ― | Downgraded | 02/23/26 | ||
| Rajesh Kumar | HSBC | $47→$54 | hold | 34.36%Upside | Reiterated | 12/10/25 | ||
| Richard Vosser | J.P. Morgan | ― | buy | ― | Reiterated | 11/24/25 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Kerry HolfordBerenberg Bank | HoldReiterated$47 | 10/13/26 | 16.94%Upside | ||
| Evan SeigermanBMO Capital | HoldReiterated$47→$40 | 10/12/26 | -0.47%Downside | ||
| Unknown AnalystJefferiesNot Ranked | HoldReiterated$42.20 | 09/22/26 | 5.00%Upside | ||
| Michael NedelcovychTD Cowen | HoldReiterated$42 | 09/22/26 | 4.50%Upside | ||
| Thibault BoutherinMorgan Stanley | SellDowngraded$40 | 09/11/26 | -0.47%Downside | ||
| Jasper HellwegArgus Research | HoldReiterated | 08/07/26 | ― | ||
| James QuigleyGoldman Sachs | HoldReiterated$48→$44 | 08/06/26 | 9.48%Upside | ||
| Martin BrenoeNordea Markets | HoldDowngraded | 02/24/26 | ― | ||
| Emmanuel PapadakisDeutsche Bank | HoldDowngraded | 02/23/26 | ― | ||
| Rajesh KumarHSBC | HoldReiterated$47→$54 | 12/10/25 | 34.36%Upside | ||
| Richard VosserJ.P. Morgan | BuyReiterated | 11/24/25 | ― |
Best Analysts Covering Novo Nordisk
Copying Richard Vosser's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +0.86% per trade.
Copying Richard Vosser's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +4.24% per trade.
Copying Richard Vosser's trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +22.97% per trade.
NVO Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 8 | 13 | 15 | 16 |
| Sell | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 6 | 8 | 13 | 16 | 17 |
In the current month, NVO has received 0 Buy Ratings, 16 Hold Ratings, and 1 Sell Ratings. NVO average Analyst price target in the past 3 months is 42.53.
NVO Financial Forecast
NVO Earnings Forecast
Next quarter’s earnings estimate for NVO is $0.73 with a range of $0.68 to $0.80. The previous quarter’s EPS was $0.96. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
NVO Sales Forecast
Next quarter’s sales forecast for NVO is $11.08B with a range of $10.68B to $11.76B. The previous quarter’s sales results were $12.21B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
